Ovarian Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Women aged 18 or older at the time of giving consent
- People who are able to provide written consent to participate
- People who have been found to have an ovarian cyst or a mass in the ovary or pelvic area (whether fluid-filled, mixed, or solid) through an imaging scan such as an internal ultrasound, and who need surgery for it but have not yet had that surgery
Who may not be able to join:
- People who have previously been diagnosed with or treated for ovarian cancer
- People who have previously had surgery that removed both ovaries
- People with a history of any gynaecological cancer within the last 2 years
- People with a history of melanoma (a type of skin cancer) within the last 2 years
- People who have received chemotherapy, radiotherapy, or immunotherapy within the 12 months before their sample would be collected
- People with a weakened immune system — this includes those with conditions such as HIV/AIDS, autoimmune diseases (such as Lupus), or primary immune deficiency disorders, as well as those who have received immune-suppressing medications (for example, transplant recipients) or have had chemotherapy, radiotherapy, or immunotherapy within the last 12 months
- People who are currently pregnant or have been pregnant within the last 3 months, based on self-reported information
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Chief Scientific Officer, Cleo Diagnostics Ltd
Phone: 1-855-264-4064
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Calculation of the CleoDX adnexal mass score
Can't join this trial?
Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.